AIM logo
Alcohol in
Moderation
  • Home
  • Articles
  • Aim Digest
  • About AIM
  • AIM Council
Subscribe
Log in
  • All articles
  • All critiques
  • All-cause mortality& alcohol
  • Cancer& alcohol
    • Breast cancer
    • Colorectal cancers
    • Head and neck cancers
    • Lung cancer
    • Prostate cancer
  • Diabetes& alcohol
  • Heart& alcohol
    • Arrhythmia
    • Cardiovascular disease
    • Coronary heart disease
    • Cholesterol
    • Heart attack
    • Heart failure
    • Hypertension
  • Antioxidants& alcohol
  • Bone mineral density& alcohol
  • The brain& alcohol
    • Cognitive decline
  • General health& alcohol
  • J-shaped curve& alcohol
  • The kidneys& alcohol
  • The liver& alcohol
  • Mediterranean diet& alcohol
  • Moderate drinking
  • Old age& alcohol
    • Cognitive decline
  • Parkinsons’ disease& alcohol
  • Rheumatoid arthritis& alcohol
  • Stroke
  • Women& alcohol
    • Breast cancer
    • Pregnancy
Choose a Topic
July 2025
Metabolic syndrome/weight

The effects of wine consumption on metabolic syndrome

Moderate alcohol use has been shown in prior research to significantly lower the risk of cardiovascular disease and metabolic syndrome. Metabolic syndrome is a major public health problem. A study analysed the effects of wine consumption on glucose, insulin, systolic blood pressure, diastolic blood pressure, and body mass index (BMI), some of the most important cardiovascular parameters associated with metabolic syndrome.
Researchers searched the MEDLINE, Scopus, Cochrane Library, and Web of Science databases from their inception until March 14, 2025, finding 2145 articles, from which 18 studies were selected for the systematic review and meta-analysis.
The pooled mean difference (MD) value of pre-post studies assessing the effects of wine consumption on the studied factors was -1.49 (95% CI: -3.40, 0.41) mg/dL for glucose, -1.45 (95% CI: -4.53, 1.64) μU/mL for insulin, -1.22 (95% CI: -2.08, -0.37) mmHg for systolic blood pressure, -0.18 (95% CI: -2.62, 2.25) mmHg for diastolic blood pressure, and -0.40 (95% CI: -1.27, 0.46) kg/m2 for BMI. The pooled MD value of randomised controlled trial and crossover studies for the effect of wine on the studied factors was 1.98 (95% CI: -0.17, 4.13) mg/dL for glucose, -1.34 (95% CI: -2.27, 0.40) μU/mL for insulin, 0.10 (95% CI: -0.07, 0.26) mmHg for systolic blood pressure, 0.34 (95% CI: -1.70, 2.37) mmHg for diastolic blood pressure, and 0.62 (95% CI: -0.31, 1.56) kg/m2 for BMI.
This systematic review and meta-analysis did not reveal any effect of wine intake on glucose, insulin, diastolic blood pressure, or BMI; a significant effect of wine consumption on systolic blood pressure was only found in pre-post studies and insulin in clinical trials. Future studies of possible effects of wine consumption on cardiovascular parameters associated with metabolic syndrome should take into account types of wine and quantities consumed, the researchers say.
Source: Lucerón-Lucas-Torres M, Guzmán-Pavón MJ, Ruiz-Grao MC, et al. The Effects of Wine Consumption on Metabolic Syndrome: A Systematic Review and Meta-Analysis of Clinical Trials, Nutrition Reviews, 2025. nuaf078,

doi.org/10.1093/nutrit/nuaf078
Drinking & You logo
Drinking & You
A global portal providing advice about responsible alcohol consumption, individual country government guidelines and your health.
Go to website
International Scientific Forum on Alcohol Research logo
International Scientific Forum on Alcohol Research
The International Scientific Forum on Alcohol Research (ISFAR) is a group of 45 specialist Professors and Medics who produce balanced and well researched analysis of emerging research papers alcohol and health.
Go to website

To receive notification of updates to the website, please subscribe here

Name(Required)

Topics

Harmful consumption

& alcohol

Healthy lifestyle

& alcohol

Genetics

& alcohol

Depression

& alcohol

Mental health

& alcohol

All-cause mortality

& alcohol

Cancer

& alcohol

Diabetes

& alcohol

Heart

& alcohol

Antioxidants

& alcohol

Bone mineral density

& alcohol

The brain

& alcohol

General health

& alcohol

Gut health

& alcohol

J-shaped curve

& alcohol

The kidneys

& alcohol

The liver

& alcohol

Mediterranean diet

& alcohol

Metabolic syndrome/weight

& alcohol

Moderate drinking

Old age

& alcohol

Parkinsons' disease

& alcohol

Rheumatoid arthritis

& alcohol

Stroke

& alcohol

Women

& alcohol

Latest articles

Health effects associated with alcohol consumption: a Burden of Proof study

Alcohol consumption and the risk of dementia in patients with depression: A nationwide cohort study

The health impacts of alcohol depend on what you drink – and how much

Metabolome contribution to sex differences in the link between alcohol consumption and type 2 diabetes

Rising global burden of alcohol-attributable breast cancer in women: Regional inequalities and temporal trends

Aim Digest

April 2026

February 2026

January 2026

December 2025

November 2025

© Alcohol In Moderation, 2026.
Web design by Rubber Duckers
Close menu
  • Home
  • Articles
  • Aim Digest
  • About AIM
  • AIM Council
Subscribe
Log in
Close menu
  • All articles
  • All critiques
  • All-cause mortality& alcohol
  • Cancer& alcohol
    • ← Back
    • Breast cancer
    • Colorectal cancers
    • Head and neck cancers
    • Lung cancer
    • Prostate cancer
  • Diabetes& alcohol
  • Heart& alcohol
    • ← Back
    • Arrhythmia
    • Cardiovascular disease
    • Coronary heart disease
    • Cholesterol
    • Heart attack
    • Heart failure
    • Hypertension
  • Antioxidants& alcohol
  • Bone mineral density& alcohol
  • The brain& alcohol
    • ← Back
    • Cognitive decline
  • General health& alcohol
  • J-shaped curve& alcohol
  • The kidneys& alcohol
  • The liver& alcohol
  • Mediterranean diet& alcohol
  • Moderate drinking
  • Old age& alcohol
    • ← Back
    • Cognitive decline
  • Parkinsons’ disease& alcohol
  • Rheumatoid arthritis& alcohol
  • Stroke
  • Women& alcohol
    • ← Back
    • Breast cancer
    • Pregnancy